Purac Acquires the Fiberlive Technology from Vivoxid Ltd.

FiberLive is a unique composite consisting of resorbable glass fibers and resorbable polymers, forming the strongest fully resorbable material available today. With the acquired technology Purac Biomaterials will further strengthen its position in the resorbable biomedical market, enabling Purac Biomaterials to develop, manufacture and market new materials with load bearing properties.

8 Aug 2012 --- Purac has announced that it has acquired the FiberLive technology from Vivoxid Ltd., Finland.

The acquisition includes the intellectual property of the FiberLive technology and its key personnel. This acquisition complements the activities of Purac Biomaterials, which develops, manufactures and markets resorbable polymers and monomers for medical applications under the Purasorb brand name.

FiberLive is a unique composite consisting of resorbable glass fibers and resorbable polymers, forming the strongest fully resorbable material available today. With the acquired technology Purac Biomaterials will further strengthen its position in the resorbable biomedical market, enabling Purac Biomaterials to develop, manufacture and market new materials with load bearing properties.

Menno Lammers, Managing Director Purac Biomaterials: "This technology will be a game changer in the orthopedic resorbable market, where load bearing properties are needed, such as trauma and spine applications. The FiberLive technology is the strongest fully resorbable material available for human implants, with strength up to 6 times higher than cortical bone, comparable to metal"